Evaxion A (EVAX) Interest Coverage Ratio (2020 - 2026)

Evaxion A (EVAX) posted Interest Coverage Ratio of 11.5 for Q1 2026, up 680.12% on a QoQ basis from 1.47 in Q4 2025, and up 18.06% year-over-year from 9.74 in Q1 2025.

Evaxion A (EVAX) Interest Coverage Ratio (2020 - 2026) Analysis & Trends

Evaxion A's Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 11.5 for Q1 2026.

  • Quarterly Interest Coverage Ratio rose 18.06% year-over-year to 11.5 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.32 (down 69.46% YoY) and the FY2025 annual result came in at 1.61, down 65.87% from the prior year.
  • Interest Coverage Ratio was 11.5 for Q1 2026 at Evaxion A, up from 1.47 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 40.5 in Q1 2022 and bottomed at 2.22 in Q3 2025.
  • A 5-year average of 13.14 and a median of 11.06 in 2022 frame the typical range for Interest Coverage Ratio.
  • Annual changes were most pronounced in 2023 — Interest Coverage Ratio jumped 178.44% — and 2025, when it sank 149.29%.
  • Evaxion A's Interest Coverage Ratio stood at 11.06 in 2022, then tumbled by 55.91% to 4.88 in 2023, then jumped by 80.19% to 8.79 in 2024, then tumbled by 83.22% to 1.47 in 2025, then surged by 680.12% to 11.5 in 2026.
  • Business Quant data shows EVAX's Interest Coverage Ratio at 11.5 in Q1 2026, 1.47 in Q4 2025, and 2.22 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 658.42
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -157.58
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 7.60
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 2.71
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 22.72
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -0.38
10 Evaxion A 1.23 Bn 1.23 Bn - 11.50

Historic Data

Download Data
DateValue
Mar 31, 2026 11.50
Dec 31, 2025 1.47
Sep 30, 2025 -2.22
Jun 30, 2025 1.74
Mar 31, 2025 9.74
Dec 31, 2024 8.79
Sep 30, 2024 4.51
Jun 30, 2024 2.25
Mar 31, 2024 17.87
Dec 31, 2023 4.88
Sep 30, 2023 31.66
Jun 30, 2023 20.42
Mar 31, 2023 20.02
Dec 31, 2022 11.06
Sep 30, 2022 11.37
Jun 30, 2022 27.82
Mar 31, 2022 40.50
Dec 31, 2021 107.24
Sep 30, 2021 21.49
Jun 30, 2021 15.41